secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autolus Therapeutics plc (AUTL)
CIK:        0001730463
Form:       8-K
Filed at:   2024-09-13T23:59:59+00:00
Accession:  0001730463-24-000099
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Autolus secures up to £18.5M landlord funding for Nucleus facility clean rooms
------------------------------------------------------------------------------

- Landlord provides up to £18.5M for improvements to Stevenage manufacturing facility.
- Annual rent will increase by ~£1.84M after improvements, capped at £2.19M.
- Lease term unchanged through September 2043.
- Amendments approved by audit committee due to director's familial relationship with landlord's parent executive.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730463/000173046324000099/0001730463-24-000099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730463/000173046324000099/autl-20240910.htm
  HTML page:      https://secwatch.observer/filing/0001730463-24-000099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer